Regeneron, Sanofi asthma drug seen as potential game changer
By Ransdell Pierson (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed e...
Read More »By Ransdell Pierson (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed e...
Read More »(Reuters) - AcelRX Pharmaceuticals Inc said its experimental drug device to treat post-operative pain met the main goal of controlli...
Read More »VIENNA (Reuters) - Austria's Intercell said on Tuesday it has won U.S. regulatory approval for pediatric use of its Ixiaro vaccine t...
Read More »
By David Morgan WASHINGTON (Reuters) - With the White House already reeling from three major controversies, some Republican lawmaker...
Read More »By Ronnie Cohen SAN FRANCISCO (Reuters) - Nearly 13,000 healthcare employees at five University of California medical centers plan t...
Read More »LONDON (Reuters) - British farmers will be the first in Europe to get a vaccine against Schmallenberg virus, a new livestock disease...
Read More »
(Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it wa...
Read More »By P.J. Huffstutter (Reuters) - Farms in two of the nation's leading pork producing states have tested positive for the potentially ...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Older men with other illnesses may not live long enough to benefit from aggressive p...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Men who get an older and less costly form of radiation after their cancerous prostat...
Read More »